Bonggi Kim News Today : Breaking News, Live Updates & Top Stories | Vimarsana

With increasing use of sodium glucose cotransporter 2 (SGLT2) inhibitors, investigators are taking a closer look at potential adverse events.

United statesSouth koreaBrian chiangMitsuboshi satoruBonggi kimJan menneKorean national health insurance serviceFlinders medical centreInternational journal of cardiologyPharmacology research perspectivesHannover medical school inKorea institute of drug safetyHarvard medical schoolHannover medical schoolAmerican journalKidney disease